BioMolTech believes that possibilities in technology advancement are limitless. New higher standards inevitably replace and succeed existing high standards. BioMolTech aims at raising the bar in accuracy and efficiency in virtual screening and molecular docking technologies. We believe the continuous advancement of computer-assisted drug design technology will uncover new and innovative opportunities for the pharma industry.

Founded in 2008, BioMolTech is a new business. However, its scientific foundation and software products have been in development for a number of years. The present version of BioMolTech Lead Finder is based on more than three years of dedicated research work by a team of computational chemists.

With geography being no barrier anymore, BioMolTech is part of the emerging community of international businesses operating in the global economic environment right from the start. BioMolTech is headquartered and maintains its legal base in Toronto, Canada. BioMolTech's main R&D office is located in Moscow, Russia where it conducts business as MolTech Ltd. BioMolTech will seek to expand its virtual and physical presence in such areas where it can provide the most expedient and efficient service and support to its customers.

BioMolTech’s Toronto office and worldwide operations have been organized, and are managed by Val Kulkov who brings in years of experience in growing a successful chemistry software business. For eight years prior to starting BioMolTech, Val was President of ACD/Labs, a leader in providing comprehensive and innovative predictive, chemical, spectroscopic, chromatographic, and database management software solutions to chemical and pharmaceutical researchers worldwide. Val holds an M.Sc. degree in Chemistry from the Moscow State University and an MBA degree from the University of Toronto.